The Organoids Global Market Report 2023, provides comprehensive information on the organoids market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Organoids Market’s Growth:
https://www.thebusinessresearchcompany.com/report/organoids-global-market-report

The global organoids market size is expected to grow from $1.14 billion in 2022 to $1.42 billion in 2023 at a compound annual growth rate (CAGR) of 25.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global organoids market size is expected to reach $3.4 billion in 2027 at a CAGR of 24.9%.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=10787&type=smp

Technological advancements are a key trend gaining popularity in the organoid market. Major companies operating in the organoid market are launching new organoid technologies to sustain their position in the market. For instance, in March 2023, MIMETAS, a Netherlands-based human tissue and disease model developer, launched a new type of adult stem cell (ASC)-derived tubular organoids as a part of the OrganoReady product line. This new organoid uses cutting-edge and innovative technology for mechanistic toxicology and drug-induced organ injury. Organoids are developed as perfused 3D tubular structures with access points on the apical and basal sides using the OrganoPlate, a patented microfluidic platform.

The organoids market is segmented:

1) By Product: Hepatic Organoid, Colorectal Organoid, Intestinal Organoid, Other Organoid
2) By Source: Pluripotent Stem Cells, Organ-Specific Adult Stem Cells
3) By Application: Developmental Biology, Disease Pathology Of Infectious Disease, Regenerative Medicine, Drug Toxicity And Efficacy Testing, Drug Discovery And Personalized Medicine, Other Applications
4) By End-User: Hospitals And Diagnostic Centers, Biotechnology And Pharmaceutical Companies, Other End-Users

North America was the largest region in the organoids market in 2022.

The table of contents in TBRC’s organoids market report includes:

Executive Summary
Market Characteristics
Market Trends And Strategies
Impact Of COVID-19
Market Size And Growth
Segmentation
Regional And Country Analysis
.

.

.

Competitive Landscape And Company Profiles
Key Mergers And Acquisitions
Future Outlook and Potential Analysis
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model